1952.HK Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 11:08):

Stats
Dzisiejszy wolumen	550 566
Średni wolumen	4.64M
Kapitalizacja rynkowa	7.98B
EPS	HKD0 ( 2024-03-28 )
Następna data zysków	( HKD0 ) 2024-06-28
Last Dividend	HKD0 ( N/A )
Next Dividend	HKD0 ( N/A )
P/E	-8.54
ATR14	HKD0.0560 (0.22%)

Wolumen Korelacja

Długi: 0.12 (neutral)

Krótki: -0.17 (neutral)

Signal:(53.527) Neutral

Everest Medicines Limited Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Everest Medicines Limited Korelacja - Waluta/Towar

-0.45
( neutral )

0.14
( neutral )

0.00
( neutral )

-0.44
( neutral )

0.63
( weak )

-0.54
( weak negative )

Everest Medicines Limited Finanse

Annual	2023
Przychody:	HKD125.93M
Zysk brutto:	HKD91.52M (72.67 %)
EPS:	HKD-2.70

FY	2023
Przychody:	HKD125.93M
Zysk brutto:	HKD91.52M (72.67 %)
EPS:	HKD-2.70

FY	2022
Przychody:	HKD12.79M
Zysk brutto:	HKD8.15M (63.69 %)
EPS:	HKD-0.830

FY	2021
Przychody:	HKD54 000.00
Zysk brutto:	HKD31 000.00 (57.41 %)
EPS:	HKD-3.44

Financial Reports:

No articles found.

Everest Medicines Limited

Everest Medicines Limited, a biopharmaceutical company, engages in discovery, licensing, clinical development, and commercialization of therapies to address critical unmet medical needs in Greater China and other Asia Pacific markets. Its pipeline products include eleven clinical-stage drug candidates for the treatment of oncology, immunology, cardio-renal, and infectious diseases. Everest Medicines Limited was incorporated in 2017 and is headquartered in Shanghai, China.